AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,541 | +25.5% | 1,440 | +58.6% | 0.00% | 0.0% |
| Q2 2023 | $15,572 | +28212.7% | 908 | -66.4% | 0.00% | -50.0% |
| Q1 2023 | $55 | +61.8% | 2,702 | +136.2% | 0.00% | +100.0% |
| Q4 2022 | $34 | -99.9% | 1,144 | -66.8% | 0.00% | 0.0% |
| Q3 2022 | $57,000 | +612.5% | 3,449 | +569.7% | 0.00% | – |
| Q2 2022 | $8,000 | -69.2% | 515 | -63.7% | 0.00% | – |
| Q1 2022 | $26,000 | -29.7% | 1,418 | -54.6% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | +311.1% | 3,124 | +654.6% | 0.00% | – |
| Q3 2021 | $9,000 | +80.0% | 414 | +76.2% | 0.00% | – |
| Q2 2021 | $5,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $12,177,880 | 24.30% |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $41,131,652 | 5.57% |
| Sofinnova Investments, Inc. | 3,758,686 | $75,812,697 | 4.85% |
| TCG Crossover Management, LLC | 1,081,274 | $21,809,297 | 4.25% |
| RA Capital Management | 8,263,982 | $166,684,517 | 3.77% |
| VR Adviser, LLC | 833,927 | $16,820,308 | 3.28% |
| GREAT POINT PARTNERS LLC | 755,620 | $15,240,855 | 2.99% |
| Cormorant Asset Management, LP | 1,561,696 | $31,499 | 2.07% |
| Octagon Capital Advisors LP | 621,712 | $12,539,931 | 1.80% |
| Ghost Tree Capital, LLC | 200,000 | $4,034,000 | 1.19% |